Literature DB >> 19871261

THE OCCURRENCE OF MUCOID POLYSACCHARIDE IN HEMOLYTIC STREPTOCOCCI OF HUMAN ORIGIN.

C V Seastone1.   

Abstract

1. A rapid method for the roughly quantitative estimation of mucoid polysaccharide in hemolytic streptococci has been described. 2. Using this method, about 94 per cent of strains from moderate or severe streptococcal infections in man have been found to produce mucoid polysaccharide in greater or less amount. In a group of streptococci from normal throats only about 8 per cent produced this substance, all of the producers falling into Lancefield's group A. 3. Of the Lancefield group A strains from both normal and infected sources, 92 per cent showed the presence of mucoid polysaccharide in culture dilutions of 1:10 or higher. 4. The probable significance of the mucoid polysaccharide in streptococcal virulence is indicated.

Entities:  

Year:  1943        PMID: 19871261      PMCID: PMC2135291          DOI: 10.1084/jem.77.1.21

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  Capsules in Young Cultures of Streptococcus hemolyticus.

Authors:  C V Seastone
Journal:  J Bacteriol       Date:  1934-11       Impact factor: 3.490

2.  THE VIRULENCE OF GROUP C HEMOLYTIC STREPTOCOCCI OF ANIMAL ORIGIN.

Authors:  C V Seastone
Journal:  J Exp Med       Date:  1939-09-30       Impact factor: 14.307

3.  VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXIN.

Authors:  E W Todd; R C Lancefield
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

4.  THE EFFECT OF A POLYSACCHARIDE-SPLITTING ENZYME ON STREPTOCOCCAL INFECTION.

Authors:  G K Hirst
Journal:  J Exp Med       Date:  1941-03-31       Impact factor: 14.307

5.  HYALURONIDASES OF BACTERIAL AND ANIMAL ORIGIN.

Authors:  K Meyer; E Chaffee; G L Hobby; M H Dawson
Journal:  J Exp Med       Date:  1941-02-28       Impact factor: 14.307

6.  STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : II. OBSERVATIONS ON THE PROTECTIVE MECHANISM AGAINST THE VIRULENT VARIANTS.

Authors:  C Lyons; H K Ward
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

  6 in total
  4 in total

1.  Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.

Authors:  Anthony R Flores; Brittany E Jewell; Randall J Olsen; Samuel A Shelburne; Nahuel Fittipaldi; Stephen B Beres; James M Musser
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

2.  Strain-Dependent Effect of Capsule on Transmission and Persistence in an Infant Mouse Model of Group A Streptococcus Infection.

Authors:  Luis Alberto Vega; Misu A Sanson; Brittany J Shah; Anthony R Flores
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

3.  Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations.

Authors:  Patrick R Shea; Stephen B Beres; Anthony R Flores; Amy L Ewbank; Javier H Gonzalez-Lugo; Alexandro J Martagon-Rosado; Juan C Martinez-Gutierrez; Hina A Rehman; Monica Serrano-Gonzalez; Nahuel Fittipaldi; Stephen D Ayers; Paul Webb; Barbara M Willey; Donald E Low; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

4.  THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  E H Kass; C V Seastone
Journal:  J Exp Med       Date:  1944-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.